| | 9820/3 | Lymphoid leukemia, NOS |
| | | t(5;11)(q33;q13) NUMA1/PDGFRB a novel fusion |
| | | Lymphocytic leukemia, NOS [obs] |
| | | Lymphatic leukemis, NOS [obs] |
| | | Subacute lymphoid leukemia [obs] |
| | | Subacute lymphocytic leukemia [obs] |
| | | Subacute lymphatic leukemia [obs] |
| | | Aleukemic lymphoid leukemia [obs] |
| | | Aleukemic lymphocytic leukemia [obs] |
| | | Aleukemic lymphatic leukemia [obs] |
| | | Lymphosarcoma cell leukemia [obs] |
| | 9823/3 | B-cell lymphocytic leukemia/small lymphocytic lymphoma (see also M-9670/3) |
| | | Chronic lymphocytic leukaemia (CLL) |
| | | del(13q) in chronic lymphocytic leukemia |
| | | del(6q) |
| | | Del(6q) in Chronic lymphocytic leukaemia (CLL) |
| | | der(8;17)(q10;q10) |
| | | dic(9;12)(p13;p13) PAX5/ETV6 |
| | | i(5)(p10) in hematological malignancies |
| | | i(3)(q10) in non-Hodgkin's lymphoma (NHL) |
| | | t(7;14)(q35;q32.1) TRB/TCL1A::inv(14)(q11q32.1) TRA-TRD/TCL1A::t(14;14)(q11;q32.1) TRA-TRD/TCL1A |
| | | -20 or monosomy 20 |
| | | +X solely in lymphomas |
| | | Small lymphocytic lymphoma |
| | | der(1)t(1;1)(p36;q11-q32) in hematopoietic malignancies |
| | | t(1;14)(p35;q32) LAPTM5/IGH |
| | | t(2;18)(p11;q21)IGK/BCL2 and IGK/KDSR |
| | | t(6;12)(q22;p13) ETV6/FRK |
| | | t(7;14)(p13;q11) |
| | | t(10;14)(q24;q32) NFKB2/IGH |
| | | t(11;14)(q11;q32) |
| | | t(14;19)(q32;p13) IGH/EPOR::t(14;19)(q32;p13) IGH/BRD4 ? |
| | | t(14;19)(q32;q13) IGH/Various Partners |
| | | t(10;14)(q24;q11) TLX1/TRD::t(7;10)(q34;q24) TRB/HOX11 |
| | | Chronic lymphocytic leukemia, B-cell type (includes all variants of BCLL) |
| | | Chronic lymphocytic leukemia |
| | | Chronic lymphoid leukemia |
| | | Chronic lymphatic leukemia |
| | 9826/3 | Burkitt cell leukemia (see also M-9687/3) |
| | | Acute leukemia, Burkitt type [obs] |
| | | B-ALL [obs] |
| | | FAB L3 [obs] |
| | | Burkitt cell leukemia |
| | | Acute lymphoblastic leukemia, mature B-cell type |
| | 9827/3 | Adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants) |
| | | Adult T-cell leukemia/lymphoma (ATLL) |
| | | der(15)t(1;15)(q11-12;p11-13) and der(15)t(1;15)(q21-25;p10-13) |
| | | i(9)(p10) |
| | | t(7;14)(q35;q32.1) TRB/TCL1A::inv(14)(q11q32.1) TRA-TRD/TCL1A::t(14;14)(q11;q32.1) TRA-TRD/TCL1A |
| | | +X solely in lymphomas |
| | | t(4;12)(q21;p13) |
| | | TAL1 (1p32) deletion in lymphoid malignancies |
| | | Adult T-cell lymphoma/leukemia |
| | | Adult T-cell lymphoma |
| | | Adult T-cell leukemia |
| | 9831/3 | T-cell large granular lymphocytic leukemia |
| | | t(7;14)(p13;q11) |
| | | T-cell large granular lymphocyte leukaemia |
| | | T-cell large granular lymphocytosis |
| | | NK-cell large granular lymphocytic leukemia |
| | | Large granular lymphocytosis, NOS |
| | | Chronic lymphoproliferative disorder of NK cells |
| | 9832/3 | Prolymphocytic leukemia, NOS |
| | 9833/3 | Prolymphocytic leukemia, B-cell type |
| | | B-cell prolymphocytic leukemia (B-PLL) |
| | | der(8;17)(q10;q10) |
| | | t(6;12)(q15;p13)/NHL (AML, T-CLD; - ; rare) |
| | 9834/3 | Prolymphocytic leukemia, T-cell type |
| | | t(7;14)(q35;q32.1) TRB/TCL1A::inv(14)(q11q32.1) TRA-TRD/TCL1A::t(14;14)(q11;q32.1) TRA-TRD/TCL1A |
| | | -20 or monosomy 20 |
| | | r(8) |
| | | T-cell prolymphocytic leukemia (T-PLL) |
| | | t(X;14)(q28;q11.2) TRA-TRD/MTCP1::t(X;7)(q28;q34) TRB/MTCP1 |
| | | t(10;14)(q24;q11) TLX1/TRD::t(7;10)(q34;q24) TRB/HOX11 |
| | 9835/3 | Precursor cell lymphoblastic leukemia, NOS (see also M-9727/3) |
| | | del(X)(p22p22) P2RY8/CRLF2::del(Y)(p11p11) P2RY8/CRLF2 |
| | | t(6;11)(q13;q12) EEF1G/OOEP |
| | | t(X;14)(p22;q32) or t(Y;14)(p11;q32) IGH/CRLF2 |
| | | Precursor cell lymphoblastic leukemia, not phenotyped |
| | | Acute lymphoblastic leukemia, NOS (see also M-9727/3) |
| | | Acute lymphoblastic leukemia, precursorcell type |
| | | Acute lymphoblastic leukemia-lymphoma, NOS |
| | | Acute lymphocytic leukemia |
| | | Acute lymphoid leukemia |
| | | Acute lymphatic leukemia |
| | | Lymphoblastic leukemia, NOS |
| | | FAB Ll [obs] |
| | | Acute lymphoblastic leukemia, L2 type, NOS |
| | | FAB L2 |
| | 9836/3 | Precursor B-cell lymphoblastic leukemia (see also M-9728/3) |
| | | TAL1 (1p32) deletion in lymphoid malignancies |
| | | Pro-B ALL |
| | | Common precursor B ALL |
| | | Pre-B ALL |
| | | Pre-pre-B ALL |
| | | Common ALL |
| | | c-ALL |
| | 9837/3 | Precursor T-cell lymphoblastic leukemia (see also M-9729/3) |
| | | NUP214/ABL1 fusion gene on amplified episomes |
| | | Biphenotypic Acute Leukaemia (BAL) |
| | | del(11)(p12p13) LMO2 |
| | | del(13q) in ALL |
| | | del(1p) solely |
| | | del(5q) in acute lymphoblastic leukemia (ALL) |
| | | del(6q) abnormalities in lymphoid malignancies |
| | | del(6q) |
| | | del(7)(p11-15) solely |
| | | del(9p) in Acute Lymphoblastic Leukemia |
| | | del(9q) solely |
| | | der(9)t(1;9)(q11-12;q34) |
| | | dic(7;12)(p10-p12;p11-p13) |
| | | dic(9;12)(p13;p13) PAX5/ETV6 |
| | | dup(1q) in ALL |
| | | Early T-cell precursor acute lymphoblastic leukemia |
| | | i(6)(p10) |
| | | i(8)(q10) in ALL |
| | | t(7;14)(q35;q32.1) TRB/TCL1A::inv(14)(q11q32.1) TRA-TRD/TCL1A::t(14;14)(q11;q32.1) TRA-TRD/TCL1A |
| | | Pediatric T-Cell Acute Lymphoblastic Leukemia |
| | | t(1;2)(p36;p21) THADA/PRDM16 |
| | | t(1;5)(p32;q31) ?/TAL1 |
| | | t(1;5)(p32;q31) without TAL1 rearrangement |
| | | t(1;7)(p34;q34) TRB/LCK |
| | | t(1;12)(q21;p13) ETV6/ARNT |
| | | t(1;7)(p32;q34) TRB/TAL1::t(1;14)(p32;q11) TRA/TAL1::1p32 rearrangements |
| | | t(1;19)(q23;p13) TCF3/PBX1 |
| | | der(21)t(1;21)(q11-12;p11-13) and der(21)t(1;21)(q21-32;p11-13) |
| | | t(2;14)(p13-16;q32) IGH/BCL11A |
| | | t(2;21)(q11;q22) |
| | | t(3;11)(q12;p15) NUP98/LNP1 |
| | | t(3;11)(q29;p15) NUP98/IQCG |
| | | t(4;11)(q21;q23) KMT2A/AFF1 |
| | | t(4;11)(q21;p15) NUP98/RAP1GDS1 |
| | | t(4;11)(q23;p15) NUP98/RAP1GDS1 |
| | | t(4;21)(q31;q22) RUNX1/? |
| | | t(5;6)(q33;q23) CEP85L/PDGFRB |
| | | t(5;7)(q35;q21) TLX3/CDK6 |
| | | t(5;9)(q35;q34) SQSTM1/NUP214 |
| | | t(5;12)(q13;p13) ?/ETV6 |
| | | t(5;14)(q35;q11) RANBP17 (or TLX3)/TRD |
| | | t(5;14)(q35;q11) TRD/NKX2-5 |
| | | t(5;14)(q35;q32) BCL11B/TLX3 |
| | | t(5;14)(q35;q32.2) BCL11B/TLX3 and NKX2-5 |
| | | t(5;17)(q13;q21) |
| | | t(6;7)(q23;q34) TRB/MYB and AHI1 |
| | | t(6;11)(q27;q23) KMT2A/AFDN |
| | | t(6;11)(q24.1;p15.5) NUP98/CCDC28A |
| | | t(6;12)(q22;p13) ETV6/FRK |
| | | inv(7)(p15q34) TRB/HOXA10::t(7;7)(p15;q34) TRB/HOXA10 |
| | | t(7;9)(q34;q32) TRB/TAL2 |
| | | t(7;9)(q34;q34) TRB/NOTCH1 |
| | | t(7;12)(q34;p13) TRB/CCND2::t(12;14)(p13;q11) TRA or TRD/CCND2 |
| | | t(7;14)(p13;q11) |
| | | t(7;14)(p15;q11) TRD/HOXA10 |
| | | t(7;14)(p15;q32) |
| | | t(7;14)(q34;q11) TRA/TRB |
| | | t(7;14)(q34;q11) TRA/TRB |
| | | t(7;19)(q34;p13) TRB/LYL1 |
| | | t(8;9)(p22;p24) PCM1/JAK2 |
| | | t(8;12)(q13;p13) ETV6/NCOA2 |
| | | t(8;14)(q24;q11) TRA/MYC |
| | | t(8;16)(p11;p13) KAT6A/CREBBP |
| | | t(8;21)(q24;q22) RUNX1/TRPS1 |
| | | t(9;14)(q34;q32) EML1/ABL1 |
| | | t(9;22)(q34;q11) BCR/ABL1 in ALL |
| | | t(X;7)(q22;q34) IRS4/TRB |
| | | t(X;10)(p11;p12) DDX3X/MLLT10 |
| | | t(X;11)(q13;q23) KMT2A/FOXO4 |
| | | t(10;10)(p12;q21) CTNNA3/ARHGAP21 |
| | | t(10;11)(p12;q21) PICALM/MLLT10 |
| | | t(10;11)(q25;p15) NUP98/ADD3 |
| | | t(1;3)(p32;p21) TCTA/TAL1 |
| | | t(11;14)(p13;q11) TRD/LMO2::t(7;11)(q35;p13) TRB/LMO2 |
| | | t(7;11)(q34;p15) TRB/LMO1::t(11;14)(p15;q11) TRD/LMO1 |
| | | t(11;18)(p15;q12) NUP98/SETBP1 |
| | | t(11;19)(q23;p13.3) KMT2A/MLLT1 |
| | | t(12;12)(p13;q13) ETV6/BAZ2A |
| | | t(12;13)(p12;q12-14) ETV6/CDX2 |
| | | t(14;21)(q11;q22) TRA/OLIG2 |
| | | der(17)t(17;17)(p13;q12-21) |
| | | t(9;12)(q34;p13) ETV6/ABL1 |
| | | TAL1 (1p32) deletion in lymphoid malignancies |
| | | T-lineage acute lymphoblastic leukemia (T-ALL) |
| | | +20 or trisomy 20 (solely) |
| | | +4 or trisomy 4 |
| | | +7 or trisomy 7 (solely) |
| | | +8 or trisomy 8 |
| | | +9 or trisomy 9 |
| | | 9p Rearrangements in ALL |
| | | 11q23 rearrangements (KMT2A) in childhood acute lymphoblastic leukemia |
| | | 11q23 rearrangements (KMT2A) in leukaemia |
| | | 12p rearrangements (ETV6) in ALL |
| | | 15q13-15 Rearrangements |
| | | t(10;14)(q24;q11) TLX1/TRD::t(7;10)(q34;q24) TRB/HOX11 |
| | | t(9;12)(p24;p13) ETV6/JAK2 |
| | | Pro-T ALL |
| | | Pre-T ALL |
| | | Cortical T ALL |
| | | Mature T ALL |
| | | T lymphoblastic leukemia/lymphoma |